0074-2306-30 |
0074-2306 |
HUMAN PRESCRIPTION DRUG |
Rinvoq |
Upadacitinib |
TABLET, EXTENDED RELEASE |
ORAL |
20190816 |
N/A |
NDA |
NDA211675 |
AbbVie Inc. |
UPADACITINIB |
15 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2306-30) |
0074-2306-70 |
0074-2306 |
HUMAN PRESCRIPTION DRUG |
Rinvoq |
Upadacitinib |
TABLET, EXTENDED RELEASE |
ORAL |
20190816 |
N/A |
NDA |
NDA211675 |
AbbVie Inc. |
UPADACITINIB |
15 mg/1 |
14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2306-70) |
0074-2310-20 |
0074-2310 |
HUMAN PRESCRIPTION DRUG |
Rinvoq |
Upadacitinib |
TABLET, EXTENDED RELEASE |
ORAL |
20190816 |
N/A |
NDA |
NDA211675 |
AbbVie Inc. |
UPADACITINIB |
30 mg/1 |
14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2310-20) |
0074-2310-30 |
0074-2310 |
HUMAN PRESCRIPTION DRUG |
Rinvoq |
Upadacitinib |
TABLET, EXTENDED RELEASE |
ORAL |
20190816 |
N/A |
NDA |
NDA211675 |
AbbVie Inc. |
UPADACITINIB |
30 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2310-30) |
0074-1043-28 |
0074-1043 |
HUMAN PRESCRIPTION DRUG |
Rinvoq |
Upadacitinib |
TABLET, EXTENDED RELEASE |
ORAL |
20220316 |
N/A |
NDA |
NDA211675 |
AbbVie Inc. |
UPADACITINIB |
45 mg/1 |
28 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-28) |
0074-1043-14 |
0074-1043 |
HUMAN PRESCRIPTION DRUG |
Rinvoq |
Upadacitinib |
TABLET, EXTENDED RELEASE |
ORAL |
20220316 |
N/A |
NDA |
NDA211675 |
AbbVie Inc. |
UPADACITINIB |
45 mg/1 |
14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-14) |